Skip to main content

MoneyWorks4Me

Zydus Lifesciences submits press release

10 Jun 2023 Evaluate

Zydus Lifesciences has submitted the press release that Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..